Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3730581013 | Cilastatin and imipenem only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3730582018 | Product containing only cilastatin and imipenem (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2846471000001113 | Imipenem + Cilastatin (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2846481000001110 | Imipenem + Cilastatin | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Imipenem + Cilastatin | Is a | Product containing cilastatin and imipenem | true | Inferred relationship | Existential restriction modifier | ||
| Imipenem + Cilastatin | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Imipenem + Cilastatin | Has active ingredient | Imipenem | true | Inferred relationship | Existential restriction modifier | 1 | |
| Imipenem + Cilastatin | Has active ingredient | Cilastatin | true | Inferred relationship | Existential restriction modifier | 2 | |
| Imipenem + Cilastatin | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Imipenem + Cilastatin | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only cilastatin and imipenem in parenteral dose form (medicinal product form) | Is a | True | Imipenem + Cilastatin | Inferred relationship | Existential restriction modifier | |
| Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection | Is a | True | Imipenem + Cilastatin | Inferred relationship | Existential restriction modifier | |
| Imipenem 500mg / Cilastatin 500mg powder for solution for injection vials | Is a | True | Imipenem + Cilastatin | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR